YK-11 Research Guide: Steroidal SARM and Myostatin Inhibition

YK-11: A Steroidal SARM and Myostatin Inhibitor

YK-11 occupies a unique position in the SARM research landscape because, unlike all other compounds in this class, it is structurally steroidal — derived from a DHT scaffold — and exerts its anabolic effects through two simultaneous mechanisms: androgen receptor partial agonism and myostatin inhibition via follistatin upregulation. This dual mechanism makes it both more complex to study and potentially more interesting for research focused on the upper limits of muscle fiber growth regulation.

Myostatin Inhibition via Follistatin

Myostatin (GDF-8) is a negative regulator of muscle mass — it signals through the ActRIIB receptor to limit muscle fiber size and satellite cell activation. Blocking myostatin or its receptor is one of the most intensively researched approaches in muscle-wasting disease pharmacology. YK-11 has been shown in vitro to increase follistatin mRNA expression in C2C12 myoblasts, and follistatin is a potent natural antagonist of myostatin. If confirmed in in vivo models, this would position YK-11 as one of very few orally active compounds capable of both AR stimulation and myostatin pathway inhibition simultaneously.

Androgen Receptor Activity

As an AR partial agonist, YK-11 activates distinct gene expression programs compared to full agonists like LGD-4033 or RAD-140. Its structural similarity to DHT means it shares some androgenic properties that fully non-steroidal SARMs avoid, and some research has flagged potential neurotoxicity at high concentrations. These factors make appropriate study design controls especially important when using YK-11.

Research Context

YK-11 is primarily used in studies focused on the maximum extent of muscle hypertrophy signaling. It is compared to Ostarine and RAD-140 for receptor pathway characterization, and to myostatin antibodies and ActRIIB pathway inhibitors for follistatin-mediated effects. Like all SARMs, it is frequently studied alongside MK-677 in dual-axis anabolic designs.

Available Formulations

See also: LGD-4033 Research Guide. For laboratory research use only.

Leave a Reply

Your email address will not be published. Required fields are marked *